Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Australia Issues GMP Clearance Warning To Foreign Drug Sponsors

This article was originally published in SRA

Executive Summary

Australian regulators have warned they will no longer give sponsors of foreign-manufactured drugs the chance to correct any omissions they might make in their applications for good manufacturing practice clearance that are based on GMP certificates issued by overseas agencies under mutual recognition agreements1.